LVTX - LAVA Therapeutics NV - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LAVA Therapeutics NV's activity chart (see below) currently has 27 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.43% with an average time for these price targets to be met of 51.22 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 06-Aug-2025. First documented stock forecast 19-Apr-2021.

Best performing analysts who are covering LVTX - LAVA Therapeutics NV:

Arthur He Daina Graybosch Jessica Fye Reni Benjamin Roger Song

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 31-Mar-2025

$1.24

$-0.5 (-28.74%)

$1.5

1 years 1 months 29 days ago
(06-Aug-2025)

3/10 (30%)

$-0.29 (-18.95%)

91

Buy Since 20-Mar-2024

$1.5

$-0.24 (-13.79%)

$6

1 years 2 months ago
(05-Aug-2025)

1/2 (50%)

$-0.01 (-0.66%)

43

Hold Since 31-Mar-2025

1 years 4 months 20 days ago
(15-May-2025)

2/9 (22.22%)

$4.79 (395.87%)

72

Hold Since 31-Mar-2025

$1

$-0.74 (-42.53%)

1 years 6 months 4 days ago
(31-Mar-2025)

0/6 (0%)

$-0.27 (-21.26%)

Buy Since 19-Apr-2021

$19

$17.26 (991.95%)

$22

4 years 5 months 15 days ago
(20-Apr-2022)

0/2 (0%)

$14.82 (354.55%)

Show more analysts

Please expand the browser size to see the chart

What is LVTX (LAVA Therapeutics NV) average time for price targets to be met?

On average it took 51 days for the stock forecasts to be reached, with an average price target met ratio of 19.43%.

Which analyst most recently updated their price target on LVTX (LAVA Therapeutics NV)?

Which analyst has the most public recommendations on LVTX (LAVA Therapeutics NV)?

has 0 price targets and 0 ratings on LVTX

Which analyst is the currently most bullish on LVTX (LAVA Therapeutics NV)?

Jessica Fye with the highest potential upside of $17.26

Which analyst is the currently most reserved on LVTX (LAVA Therapeutics NV)?

Daina Graybosch with the lowest potential downside of -$0.74
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?